Lam Research (LRCX) Tops Q3 EPS by 12c, Offers Guidance

Lam Research (NASDAQ: LRCX) reported Q3 EPS of $1.47, $0.12 better than the analyst estimate of $1.35. Revenue for the quarter came in at $5.84 billion versus the consensus estimate of $5.73 billion.

GUIDANCE:

Lam Research sees Q4 2026 EPS of $1.50-$1.80, versus the consensus of $1.45. Lam Research sees Q4 2026 revenue of $6.2-7 billion, versus the consensus of $6.05 billion.

For earnings history and earnings-related data on Lam Research (LRCX) click here.

You May Also Be Interested In

• Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c